Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Educational Conference in Israel Marks World Down Syndrome Day

As part of World Down Syndrome Day, about 100 people participated in a conference at Hadassah Hospital-Mount Scopus on April 6, 2014, affording families of patients with Down syndrome from all over Israel an opportunity to meet with eminent specialists.

Hadassah's National Center for Down Syndrome on Mount Scopus, established 10 years ago under the direction of Dr. Ariel Tenenbaum, was one of the hosts. Hadassah’s Down syndrome center is a multidisciplinary, "one-stop shop" for individuals with "Trisomy 21," the other name for Down syndrome, indicating that those with the syndrome have three, rather than the usual pair, of #21 chromosomes.

This year’s conference zeroed in on the relationships within the family (parents, siblings, and others) and issues of integration into the community. In addition, Dr. Tenenbaum highlighted ongoing research projects at the Center and the various initiatives under his leadership.

The concept for an annual conference about Down syndrome was initiated in 2006 by Balbir Singh of the Singapore Down Syndrome Association and Joav Merrick of the National Institute of Child Health and Human Development (NICHD) in Israel.

These annual conferences are a collaboration among Hadassah, NICHD, the Ministry of Social Affairs, the Municipality of Jerusalem, the Jerusalem Down Syndrome Association (Yated), Keren Shalem, and the SHALVA Center in Jerusalem.

Date: 4/18/2014


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America